Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries
An L, Zheng R, Zhang S, Chen R, Wang S, Sun K, Lu L, Zhang X, Zhao H, Zeng H, Wei W, He J. Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries. HepatoBiliary Surgery And Nutrition 2023, 0: 0-0. PMID: 36860251, PMCID: PMC9944524, DOI: 10.21037/hbsn-21-75.Peer-Reviewed Original ResearchPopulation-based cancer registriesAge-standardized ratesOverall age-standardized rateIncidence of HCCIntrahepatic cholangiocarcinomaHepatocellular carcinomaICC incidenceHCC incidenceCancer RegistryNationwide incidencePopulation-based cancer registry dataHepatitis B virus (HBV) vaccinationB virus vaccinationHepatitis B vaccinationLiver cancer incidenceEnd Results ProgramPopulation-based registryPrimary liver cancerCancer registry dataLiver cancer casesHealthy lifestyle promotionLiver cancer controlLiver cancer subtypesOverall Hepatocellular carcinomaB vaccinationDisparities in stage at diagnosis for liver cancer in China
Shan T, Ran X, Li H, Feng G, Zhang S, Zhang X, Zhang L, Lu L, An L, Fu R, Sun K, Wang S, Chen R, Li L, Chen W, Wei W, Zeng H, He J. Disparities in stage at diagnosis for liver cancer in China. Journal Of The National Cancer Center 2023, 3: 7-13. PMID: 39036312, PMCID: PMC11256694, DOI: 10.1016/j.jncc.2022.12.002.Peer-Reviewed Original ResearchLiver cancerStage IIIStage distributionHospital-based studyProportion of patientsLiver Cancer stagePrimary liver cancerCancer control policiesCancer awarenessCancer stageTreatment strategiesFamily historyStudy populationStage ISocioeconomic populationsCancerLogistic regressionPatientsDiagnosisEarly detectionHigher proportionDifferent populationsPopulationProportionHospital